section name header

Indications

REMS

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Derm: rash, ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS, DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS), EXFOLIATIVE DERMATITIS, photosensitivity, STEVENS-JOHNSON SYNDROME (SJS), TOXIC EPIDERMAL NECROLYSIS (TEN), yellow discoloration.

GI: anorexia, diarrhea, nausea, vomiting, drug-induced hepatitis.

GU: crystalluria, infertility, oligospermia, orange-yellow discoloration of urine, renal impairment.

Hemat: AGRANULOCYTOSIS, APLASTIC ANEMIA, blood dyscrasias, eosinophilia, hemolytic anemia, megaloblastic anemia, thrombocytopenia.

Neuro: headache, peripheral neuropathy.

Resp: pneumonitis.

Misc: fever, HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS AND ANGIOEDEMA).

Interactions

Drug-Drug:

Drug-Food:

Availability

(Generic available)

Route/Dosage

see Calculator

Ulcerative Colitis

Rheumatoid Arthritis

US Brand Names

Azulfidine, Azulfidine EN-tabs

Action

Therapeutic Effects:

Classifications

Therapeutic Classification: antirheumatics (DMARD), gastrointestinal anti-inflammatories

Pharmacokinetics

Absorption: 10–15% absorbed after oral administration.

Distribution: Widely distributed; crosses the placenta and enters breast milk.

Protein Binding: 99%.

Metabolism/Excretion: Split by intestinal bacteria into sulfapyridine and 5-aminosalicylic acid. Some absorbed sulfasalazine is excreted by bile back into intestines; 15% excreted unchanged by the kidneys. Sulfapyridine also excreted mostly by the kidneys.

Half-life: 6 hr.

Canadian Brand Names

Salazopyrin

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
PO1 hr1.5–6 hr6–12 hr

Patient/Family Teaching

Pronunciation

sul-fa-SAL-a-zeen

Code

NDC Code*